Hemophagocytic lymphohistiocytosis (HLH) is a rare disease that usually occurs in infants and young children. It may also occur in adults. Children usually inherit the disease. In adults, many different conditions, including infections and cancer, can cause HLH.
If you have HLH, your body's defense system, called your immune system, does not work normally. Certain white blood cells — histiocytes and lymphocytes — attack your other blood cells. These abnormal blood cells collect in your spleen and liver, causing these organs to enlarge.
What causes HLH?
HLH is a rare disease, and healthcare providers are still learning about its causes. There are 2 types of HLH: familial and acquired. Familial HLH accounts for about 25% of cases and families pass down the condition. If both parents are genetic carriers of HLH, a child has a 25% chance of having the disease, a 25% chance of not having the disease, and a 50% chance of being a carrier. A number of conditions cause acquired HLH. These include:
Viral infections, especially Epstein-Barr virus
A weak or diseased immune system
What are the symptoms of HLH?
Fever and enlargement of the spleen are the most common symptoms of HLH. There are many other possible symptoms, including:
Enlargement of your liver
Swollen lymph nodes
Jaundice (yellow color of your skin and eyes)
Lung problems, including coughing and difficulty breathing
Digestive problems, including stomachache, vomiting, and diarrhea
Nervous system problems, including headache, trouble walking, visual disturbances, and weakness
Young children and babies may have additional symptoms, like irritability and “failure to thrive." This means they don’t grow and develop normally.
How is HLH diagnosed?
Your healthcare provider bases a diagnosis of HLH on your symptoms, physical exam findings, and several lab tests. A prolonged fever is a commonly occurring symptom. An enlarged liver or spleen (located in the upper left side of the abdomen) are key physical findings. Your healthcare provider conducts blood tests to look for:
Low levels of white blood cells called natural killer cells (these cells are important for a healthy immune system)
Low levels of white blood cells, red blood cells, and clotting cells called platelets
High levels of triglycerides (fats in your blood)
Low levels of fibrinogen (a protein important for clotting)
High levels of ferritin (a protein that stores iron)
High levels of a substance called CD25 which increases in your blood when your immune system is stimulated
Another important test, a bone marrow biopsy, calls for taking a sample of your bone marrow (the center of the bone, where blood cells are made) and examining it under a microscope. Other tests may include genetic testing and blood cultures, which are blood samples, to look for infection in your blood.
How is HLH treated?
Treatment of HLH depends on the cause, your age when the disease starts, and how severe the disease is. The acquired form of HLH may clear up when your healthcare provider identifies the cause and treats the disease. Familial-type HLH is usually fatal if not treated. Treatment for familial or persistent acquired HLH may include:
Chemotherapy (cancer drugs)
Immunotherapy (drugs that affect your immune system)
Steroids (drugs that fight inflammation)
If drug treatments do not work, your healthcare providers may do a stem cell transplant. In this procedure, healthy bone marrow cells from a donor replace your diseased bone marrow cells. Stem cell transplant can cure HLH in most cases.
There is no way to prevent HLH, but as healthcare providers continue to learn more about it, treatment improves. Most children who are successfully treated go on to live normal lives.
Healthcare providers do not regularly do genetic testing for HLH on newborns, because the disease is very rare. If a healthcare provider diagnoses HLH in the brother or sister of a newborn, the chance of the newborn having the disease is 25%. Experts recommend genetic testing for these infants.
March 22, 2017
Clinical features and diagnosis of hymophagocytic lymphohistiocytosis, Up To Date, Morimoto, A., Hemophagocytic lymphohistiocytosis: Pathogenesis, diagnosis, and management (2016); 58; 817-825, Treatment and Prognosis of Hemophagocytic lymphohistiocytosis, UpToDate
Freeborn, Donna, PhD, CNM, FNP,Gersten, Todd, MD